Literature DB >> 26710046

A Systematic Review of Comparison of Autologous, Allogeneic, and Synthetic Augmentation Grafts in Nipple Reconstruction.

Sebastian Winocour1, Anshuman Saksena, Christine Oh, Peter S Wu, Alexis Laungani, Heather Baltzer, Michel Saint-Cyr.   

Abstract

BACKGROUND: Many techniques have been described for nipple reconstruction, with the principal limitation being excessive loss of projection. The ideal reconstructed nipple provides sustained projection, the fewest complications, and high levels of patient satisfaction. A variety of materials are available for projection augmentation, including autologous, allogeneic, and synthetic materials. To date, there has been no systematic review to study the efficacy, projection, and complication rates of different materials used in nipple reconstruction.
METHODS: MEDLINE, Embase, and PubMed databases were searched, from inception to August of 2014, to identify literature reporting on outcomes of autologous, allogeneic, and synthetic grafts in nipple reconstruction. Retrospective and prospective studies with controlled and uncontrolled conditions were included. Studies reporting the use of autologous flap techniques without grafts and articles lacking postoperative outcomes were excluded. Study quality was assessed using the Newcastle-Ottawa Scale.
RESULTS: Thirty-one studies met the inclusion criteria. After evidence review, one study represented two of nine stars on the Newcastle-Ottawa Scale, two studies represented three stars, six studies represented four stars, seven studies represented five stars, 11 studies represented six stars, and four studies represented seven stars.
CONCLUSIONS: The results of this review revealed heterogeneity in the type of material used within each category and inconsistent methodology used in outcomes assessment in nipple reconstruction. Overall, the quality of evidence is low. Synthetic materials have higher complication rates and allogeneic grafts have nipple projection comparable to that of autologous grafts. Further investigation with high-level evidence is necessary to determine the optimal material for nipple reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

Entities:  

Mesh:

Year:  2016        PMID: 26710046     DOI: 10.1097/PRS.0000000000001861

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  7 in total

1.  Use of acellular dermal matrix (ADM) in nipple reconstruction: the 'central-pillar technique'.

Authors:  Russell J Bramhall; Paul T R Thiruchelvam; Mae Concepcion; Gerald P Gui
Journal:  Gland Surg       Date:  2017-08

2.  Simultaneous nipple reconstruction in autologous breast reconstruction.

Authors:  Jong Ho Lee; Jeong Yeop Ryu; Jung Ho Lee; Jeeyeon Lee; Ho Yong Park; Jung Dug Yang; Joon Seok Lee
Journal:  Gland Surg       Date:  2021-10

Review 3.  Nipple-Areola Complex Reconstruction.

Authors:  Andrea Sisti
Journal:  Medicina (Kaunas)       Date:  2020-06-16       Impact factor: 2.430

4.  One injection for a great projection: a quick and simple procedure for nipple reconstruction.

Authors:  Sara Tanini; Sara Calabrese; Elena Lucattelli; Giulia Lo Russo
Journal:  Arch Plast Surg       Date:  2021-03-15

5.  A new role for syringes in breast reconstruction: An easy and cheap dressing to protect reconstructed nipples.

Authors:  M Faenza; E Grella; L Castiello; R Grieco; G A Ferraro
Journal:  JPRAS Open       Date:  2020-12-03

6.  The "Five-flap" Technique for Nipple-Areola Complex Reconstruction.

Authors:  Giuseppe Andrea Ferraro; Giuseppe Lanzano; Corrado Gentile; Sara Izzo; Elisa Grella; Adelmo Gubitosi; Giovanni Francesco Nicoletti
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-11-04

Review 7.  Guiding Nipple-Areola Complex Reconstruction: Literature Review and Proposal of a New Decision-Making Algorithm.

Authors:  Guido Paolini; Guido Firmani; Francesca Briganti; Michail Sorotos; Fabio Santanelli di Pompeo
Journal:  Aesthetic Plast Surg       Date:  2020-11-20       Impact factor: 2.326

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.